News of Note—Gardasil-Cervarix divide, flu vaccines and more

newspapers
(Pixabay)

Here is some other vaccine news of note for the week:

> Starting from this fall, students in Quebec are receiving one shot of Merck & Co.’s Gardasil 9 and then later a shot of GlaxoSmithKline’s Cervarix to protect against HPV. Experts worry the new program will not build sufficient immunity to seven of the nine strains not covered in Cervarix. The Globe and Mail article

> Italy’s health minister, Giulia Grillo, from the vaccine-skeptic party Five Star Movement, has sacked the entire board of the country’s health advisory committee. The Guardian article

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

> An ongoing shortage of GlaxoSmithKline’s popular shingles vaccine, Shingrix, has caused frustration among people waiting to get it. The Boston Globe article

> About 60% of people 60 and older in the U.S. have gotten a flu shot this season, according to new data from Clover Health. UPI article

> The global vaccines market is expected to reach $57.5 billion by 2025, up from from $33.7 billion in 2018, according to a report from Meticulous Research. Release